Phthalates, BPA/BPS, PFAS, glyphosate, mycotoxins; act as xenoestrogens, AhR agonists, and mitochondrial toxins.
Symptom connections · 42
Connections describe mechanisms, not proof that a molecule causes a symptom. Tissue, regulation and clinical context matter.
PCOS (PMOS)Indirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Aromatised excess androgens; unopposed by low progesterone.
Hashimoto'sIndirect connection · emerging
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estrogen raises TBG and shifts autoimmune risk.
Thyroid dysfunctionIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Raises TBG, lowers free T3.
EndometriosisIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Local aromatase in lesions sustains growth.
DepressionIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Histamine: E2 primes mast cell degranulation and suppresses DAO. · emerging
Histamine → Dopamine: H3 heteroreceptors modulate dopamine release. · emerging
Anhedonia tracks meso-limbic DA.
Brain fogIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Mast cell: Estrogen sensitises mast cells and downregulates DAO. · emerging
Mast cell → Chronic inflammation: Chronic MCAS drives sustained cytokine release. · emerging
Cytokines cross BBB and slow cognition.
InsomniaIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Histamine: E2 primes mast cell degranulation and suppresses DAO. · emerging
H1 tone maintains wakefulness (HNMT clearance).
ADHDIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Histamine: E2 primes mast cell degranulation and suppresses DAO. · emerging
Histamine → Dopamine: H3 heteroreceptors modulate dopamine release. · emerging
Meso-cortical DA tone gates attention.
ASD (systems view)Indirect connection · emerging
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Progesterone: Estrogen-dominant proliferative signal is opposed by luteal progesterone. · established
Progesterone → GABA: Allopregnanolone is a positive allosteric modulator of GABA-A. · established
Reduced GABAergic inhibition in some cohorts.
AnxietyIndirect connection · emerging
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Histamine: E2 primes mast cell degranulation and suppresses DAO. · emerging
TMN histamine promotes arousal.
MigraineIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Perimenstrual estrogen drop triggers attacks.
Leaky gut / intestinal permeabilityIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Mast cell: Estrogen sensitises mast cells and downregulates DAO. · emerging
Mast cell → Chronic stress: CRH activates mast cells via CRH-R1 independent of IgE. · established
CRH raises permeability acutely.
ConstipationIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Mast cell: Estrogen sensitises mast cells and downregulates DAO. · emerging
Mast cell → Chronic stress: CRH activates mast cells via CRH-R1 independent of IgE. · established
Sympathetic dominance suppresses motility.
Mast cell activationIndirect connection · emerging
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Sensitises mast cells; suppresses DAO.
AutoimmunityIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Female-predominant autoimmunity is estrogen-modulated.
LipedemaIndirect connection · emerging
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Onset at puberty/pregnancy/perimenopause implicates estrogen.
Chronic fatigueIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Progesterone: Estrogen-dominant proliferative signal is opposed by luteal progesterone. · established
Progesterone → Cortisol: Progesterone and cortisol share pregnenolone precursor — 'pregnenolone steal'. · emerging
Blunted CAR predicts fatigue.
Long COVIDIndirect connection · emerging
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Mast cell: Estrogen sensitises mast cells and downregulates DAO. · emerging
Post-viral MCAS overlap.
POTS / dysautonomiaIndirect connection · emerging
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Mast cell: Estrogen sensitises mast cells and downregulates DAO. · emerging
MCAS overlap in flushing subtype.
IBSIndirect connection · emerging
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Mast cell: Estrogen sensitises mast cells and downregulates DAO. · emerging
Mucosal mast cell density correlates with pain.
HypertensionIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Mast cell: Estrogen sensitises mast cells and downregulates DAO. · emerging
Mast cell → Chronic stress: CRH activates mast cells via CRH-R1 independent of IgE. · established
Cortisol + catecholamines sustain elevated BP.
Cardiovascular diseaseIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Mast cell: Estrogen sensitises mast cells and downregulates DAO. · emerging
Mast cell → Chronic inflammation: Chronic MCAS drives sustained cytokine release. · emerging
IL-6/TNF sustain plaque progression.
DementiaIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Mast cell: Estrogen sensitises mast cells and downregulates DAO. · emerging
Mast cell → Chronic inflammation: Chronic MCAS drives sustained cytokine release. · emerging
Microglial activation drives synaptic loss.
Bipolar disorderIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Histamine: E2 primes mast cell degranulation and suppresses DAO. · emerging
Histamine → Dopamine: H3 heteroreceptors modulate dopamine release. · emerging
Mania linked to hyperdopaminergic state.
PTSDIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Histamine: E2 primes mast cell degranulation and suppresses DAO. · emerging
Histamine → Threat (sympathetic): Tuberomammillary histamine promotes wakefulness and arousal. · emerging
Persistent sympathetic dominance.
Graves' diseaseIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Female preponderance; postpartum triggers.
Cushing syndromeIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Progesterone: Estrogen-dominant proliferative signal is opposed by luteal progesterone. · established
Progesterone → Cortisol: Progesterone and cortisol share pregnenolone precursor — 'pregnenolone steal'. · emerging
Sustained hypercortisolism is the causal engine.
Addison's diseaseIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Progesterone: Estrogen-dominant proliferative signal is opposed by luteal progesterone. · established
Progesterone → Cortisol: Progesterone and cortisol share pregnenolone precursor — 'pregnenolone steal'. · emerging
Absolute deficiency drives fatigue, hypotension.
DysmenorrheaIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Unopposed estrogen thickens endometrium.
Female infertilityIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Progesterone: Estrogen-dominant proliferative signal is opposed by luteal progesterone. · established
Luteal-phase deficiency prevents implantation.
Pre-eclampsiaIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Mast cell: Estrogen sensitises mast cells and downregulates DAO. · emerging
Mast cell → Chronic inflammation: Chronic MCAS drives sustained cytokine release. · emerging
sFlt-1 / PlGF imbalance.
Uterine fibroids (leiomyoma)Indirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Drives fibroid growth via ERα.
Metabolic syndromeIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Mast cell: Estrogen sensitises mast cells and downregulates DAO. · emerging
Mast cell → Chronic inflammation: Chronic MCAS drives sustained cytokine release. · emerging
Adipose IL-6/TNF worsens IR.
Type 2 diabetesIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Mast cell: Estrogen sensitises mast cells and downregulates DAO. · emerging
Mast cell → Chronic inflammation: Chronic MCAS drives sustained cytokine release. · emerging
Adipose cytokines worsen IR.
ObesityIndirect connection · emerging
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Histamine: E2 primes mast cell degranulation and suppresses DAO. · emerging
Histamine → Dopamine: H3 heteroreceptors modulate dopamine release. · emerging
Hedonic override of homeostatic signals.
Rheumatoid arthritisIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Mast cell: Estrogen sensitises mast cells and downregulates DAO. · emerging
Mast cell → IL-6: Mast cells release TNF-α and IL-6 alongside histamine. · established
Sustains synovial inflammation.
Systemic lupus erythematosusIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estrogen dose-responsively promotes autoimmunity.
Multiple sclerosisIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Mast cell: Estrogen sensitises mast cells and downregulates DAO. · emerging
Mast cell → Chronic inflammation: Chronic MCAS drives sustained cytokine release. · emerging
Systemic + CNS cytokines.
FibromyalgiaIndirect connection · emerging
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Progesterone: Estrogen-dominant proliferative signal is opposed by luteal progesterone. · established
Progesterone → GABA: Allopregnanolone is a positive allosteric modulator of GABA-A. · established
Reduced inhibitory tone in central pain circuits.
PsoriasisIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Mast cell: Estrogen sensitises mast cells and downregulates DAO. · emerging
Mast cell → Chronic stress: CRH activates mast cells via CRH-R1 independent of IgE. · established
Flares track stress episodes.
Atopic dermatitisIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Mast cell: Estrogen sensitises mast cells and downregulates DAO. · emerging
Skin mast cells drive itch and inflammation.
Allergic rhinitisIndirect connection · established
Environmental toxins → Estradiol: Xenoestrogens (BPA, phthalates) act at ER receptors. · emerging
Estradiol → Mast cell: Estrogen sensitises mast cells and downregulates DAO. · emerging
Degranulation drives sneeze, congestion, itch.